Double-blind randomized trial of buprenorphine and methadone in opiate dependence.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Drug and Alcohol Dependence

• Publication date

  2001-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0376-8716(00)00163-0PMID 11173173
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma concentrations of buprenorphine 24 to 72 hours after dosing.

  1999cited by this paper
• Buprenorphine versus methadone maintenance for the treatment of opioid dependence.

  1999cited by this paper
• Pharmacokinetic comparison of the buprenorphine sublingual liquid and tablet.

  1999cited by this paper
• Buprenorphine Pharmacokinetics: Relative Bioavailability of Sublingual Tablet and Liquid Formulations

  1999cited by this paper
• Alternate-day buprenorphine dosing is preferred to daily dosing by opioid-dependent humans

  1998cited by this paper
• Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial.

  1998cited by this paper
• Six deaths linked to concomitant use of buprenorphine and benzodiazepines.

  1998cited by this paper
• Comparison of Buprenorphine and Methadone in the Treatment of Opioid Dependence

  1998cited by this paper
• Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse.

  1997cited by this paper
• A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence.

  1996cited by this paper
• Comparison of buprenorphine and methadone in the treatment of opioid dependence.

  1994influential reference
• Buprenorphine versus Methadone Maintenance for Opioid Dependence

  1993cited by this paper
• A controlled trial of buprenorphine treatment for opioid dependence.

  1992cited by this paper
• The Effectiveness of Methadone Maintenance Treatment

  1991cited by this paper
• Buprenorphine responders: a diagnostic subgroup of heroin addicts?

  1991cited by this paper
• Use of buprenorphine in the treatment of opioid addiction. II. Physiologic and behavioral effects of daily and alternate‐day administration and abrupt withdrawal

  1990cited by this paper
• A clinical trial of buprenorphine: Comparison with methadone in the detoxification of heroin addicts

  1988cited by this paper
• Buprenorphine.

  1985cited by this paper
• Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction.

  1978cited by this paper
• The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.

  1976cited by this paper
• Problems of Drug Dependence

  1969cited by this paper

• Buprenorphine: New Challenges and Opportunities

  2025cites this paper
• Relative risks of adverse effects across different opioid agonist treatments-A systematic review and meta-analysis.

  2025cites this paper
• Empirically contrasting urine drug screening-based opioid use disorder treatment outcome definitions.

  2024cites this paper
• Assessing fragility of statistically significant findings from randomized controlled trials assessing pharmacological therapies for opioid use disorders: a systematic review

  2024cites this paper
• Cost-effectiveness of full and partial opioid agonists for opioid use disorder in outpatient settings: United States healthcare sector perspective.

  2023cites this paper
• Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies.

  2023cites this paper
• Effects of buprenorphine on opioid craving in comparison to other medications for opioid use disorder: A systematic review of randomized controlled trials.

  2022cites this paper
• Buprenorphine/naloxone and methadone effectiveness for reducing craving in individuals with prescription opioid use disorder: Exploratory results from an open-label, pragmatic randomized controlled trial.

  2022cites this paper
• Flexible Buprenorphine/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled Trial.

  2022cites this paper
• Intra-individual variability and stability of affect and craving among individuals receiving medication treatment for opioid use disorder

  2022cites this paper
• Relative effectiveness of medications for opioid-related disorders: A systematic review and network meta-analysis of randomized controlled trials

  2022influential citation
• Measuring treatment attrition at various stages of engagement in Opioid Agonist Treatment in Ontario Canada using a cascade of care framework

  2022cites this paper
• Opioid agonist treatment for people who are dependent on pharmaceutical opioids.

  2022cites this paper
• Buprenorphine/naloxone versus methadone opioid rotation in patients with prescription opioid use disorder and chronic pain: study protocol for a randomized controlled trial

  2022cites this paper
• In-Kind Welfare Benefits and Recidivism Risk: Evidence from Medicaid

  2021cites this paper
• Slow release oral morphine versus methadone for opioid use disorder in the fentanyl era (pRESTO): Protocol for a non-inferiority randomized clinical trial.

  2020cites this paper
• Comparative effectiveness of buprenorphine-naloxone versus methadone for treatment of opioid use disorder: a population-based observational study protocol in British Columbia, Canada

  2020cites this paper
• Effects of Medication-Assisted Treatment (MAT) for Opioid Use Disorder on Functional Outcomes: A Systematic Review.

  2020cites this paper
• Buprenorphine implants: review of literature evidence and impacts on subjects with opioid use disorders

  2020cites this paper
• Determinants of selection into buprenorphine/naloxone among people initiating opioid agonist treatment in British Columbia.

  2019cites this paper
• Full A Call for Consensus in Defining Efficacy in Clinical Trials for Opioid Addiction: Combined Results from a Systematic Review and Qualitative Study in Patients Receiving Pharmacological Assisted Therapy for Opioid Use Disorder

  2019cites this paper
• A call for consensus in defining efficacy in clinical trials for opioid addiction: combined results from a systematic review and qualitative study in patients receiving pharmacological assisted therapy for opioid use disorder

  2019cites this paper
• Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence (Review)

  2019cites this paper
• Concomitant Heroin and Cocaine Use among Opioid-Dependent Patients during Methadone, Buprenorphine or Morphine Opioid Agonist Therapy

  2019cites this paper
• A systematic review of sex differences in treatment outcomes among people with opioid use disorder receiving buprenorphine maintenance versus other treatment conditions.

  2019cites this paper
• Methadone and Buprenorphine for the Treatment of Opiate Addiction

  2018cites this paper
• Probuphine® (buprenorphine implant): a promising candidate in opioid dependence

  2017cites this paper
• Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence: A Randomized Clinical Noninferiority Trial

  2017cites this paper
• Effectiveness and cost-effectiveness of unsupervised buprenorphine-naloxone for the treatment of heroin dependence in a randomized waitlist controlled trial.

  2017cites this paper
• Voriconazole more likely than posaconazole increases plasma exposure to sublingual buprenorphine causing a risk of a clinically important interaction

  2016cites this paper
• Effectiveness and efficiency of substitutive drugs in opiates addiction treatment : summary

  2016cites this paper
• What Works? A Meta-Analysis of Quantitative Studies Regarding Heroin Policy

  2016cites this paper
• Time-Course of Buprenorphine Dose Increase in a Maintenance Program for Heroin Addicts: Retention in Treatment and Clinical Meaning

  2016cites this paper
• Factors that impact opioid agonist therapy in Northern and Rural Ontario

  2016cites this paper
• An overview of the disease model for drug addiction and interventions used to address the current opioid epidemic

  2016cites this paper
• Opiate treatment in the criminal justice system: a review of crimesolutions.gov evidence rated programs

  2016cites this paper
• Growing Implications for Primary Care

  2016cites this paper
• Substance Misuse: Substitution Drugs

  2016cites this paper
• Use of microdoses for induction of buprenorphine treatment with overlapping full opioid agonist use: the Bernese method

  2016cites this paper
• Major Depressive Disorder and Kappa Opioid Receptor Antagonists

  2016cites this paper
• Opioid Receptor Agonists and Antagonists

  2016cites this paper
• Opioid agonist treatment for pharmaceutical opioid dependent people.

  2016cites this paper
• Evaluation of the “Pipeline” for Development of Medications for Cocaine Use Disorder: A Review of Translational Preclinical, Human Laboratory, and Clinical Trial Research

  2016cites this paper
• Opiate treatment in the criminal justice system: a review of crimesolutions.gov evidence rated programs

  2016cites this paper
• Alpha blockers to speed ureteral stone passage.

  2015cites this paper
• Buprenorphine Maintenance vs. Methadone Maintenance or Placebo for Opioid Use Disorder.

  2015cites this paper
• Considerations on the role of buprenorphine in recovery from heroin addiction from a UK perspective

  2015cites this paper
• The relative risk of fatal poisoning by methadone or buprenorphine within the wider population of England and Wales

  2015cites this paper
• Chronic Pain: A Red Herring or Risk Factor in the Management of Patients Receiving Opioid Substitution Therapy

  2015cites this paper
• A naturalistic comparison of the effectiveness of methadone and two sublingual formulations of buprenorphine on maintenance treatment outcomes: findings from a retrospective multisite study.

  2014cites this paper
• Safety and tolerability of slow-release oral morphine versus methadone in the treatment of opioid dependence.

  2014cites this paper
• Opioid maintenance therapy in Switzerland: an overview of the Swiss IMPROVE study.

  2014cites this paper
• Association between methadone dose and concomitant cocaine use in methadone maintenance treatment: a register-based study

  2014cites this paper
• Association between gene variants and response to buprenorphine maintenance treatment.

  2014cites this paper
• From methadone to buprenorphine: changes during a 10 year period within a national opioid maintenance treatment programme.

  2014cites this paper
• Therapeutic Class Overview

  2014cites this paper
• Therapeutic Class Overview Attention Deficit/Hyperactivity Disorder (ADHD) Agents and Stimulants

  2014cites this paper
• Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.

  2014cites this paper
• Induction of pregnant women onto opioid-agonist maintenance medication: an analysis of withdrawal symptoms and study retention.

  2013cites this paper
• Pharmacological therapies for maintenance treatments of opium dependence.

  2013cites this paper
• Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European American females

  2013cites this paper
• Study on the effect of buprenorphine on neurotransmitter levels in morphine dependence rat

  2013cites this paper
• Update on the clinical use of buprenorphine: in opioid-related disorders.

  2012cites this paper
• Agonist treatment in opioid use: advances and controversy.

  2012cites this paper
• Buprenorphine in TheTreatment of Heroin Addiction

  2012cites this paper
• Mise à jour sur l’utilisation clinique de la buprénorphine

  2012cites this paper
• A systematic review: the role of spirituality in reducing depression in people living with HIV/AIDS.

  2012cites this paper
• Buprenorphine in The Treatment of Heroin Addiction

  2012cites this paper
• Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain

  2012cites this paper
• TREATMENT FOR PERSONS WITH HEROIN ADDICTION

  2012cites this paper
• Buprenorphine versus methadone use in opiate detoxification, are there other factors that should be considered?

  2012cites this paper
• Timing of buprenorphine adoption by privately funded substance abuse treatment programs: the role of institutional and resource-based interorganizational linkages.

  2012cites this paper
• Buprenorphine as an Efficacious Treatment for Opioid Dependency? A Survey of Counselors Attitudes

  2011cites this paper
• Buprenorphine as an Efficacious Treatment for Opioid Dependency? A Survey of Counselors Attitudes

  2011cites this paper
• A comparison of buprenorphine induction strategies: patient-centered home-based inductions versus standard-of-care office-based inductions.

  2011cites this paper
• Participant Characteristics and Buprenorphine Dose

  2011cites this paper
• Subjective effects of prisoners using buprenorphine for detoxification.

  2011cites this paper
• The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Substance Use and Related Disorders. Part 2: Opioid dependence

  2011cites this paper
• Treatment practices and perceived challenges for European physicians treating opioid dependence

  2010cites this paper
• Heroin-Dependent Inmates' Experiences with Buprenorphine or Methadone Maintenance

  2010cites this paper
• Buprenorphine in maintenance treatment: experience among Italian physicians in drug addiction centers.

  2010cites this paper
• The pharmacological treatment of opioid addiction—a clinical perspective

  2010cites this paper
• The SUMMIT trial: a field comparison of buprenorphine versus methadone maintenance treatment.

  2010cites this paper
• Therapie der Opioidabhängigkeit - ein Update

  2010cites this paper
• Place of buprenorphine in the management of opioid dependence

  2009cites this paper
• Opioid dependence treatment: options in pharmacotherapy

  2009cites this paper
• Services for heroin withdrawal: A review

  2009cites this paper
• Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: patient characteristics and patterns and predictors of treatment retention.

  2009cites this paper
• Buprenorphine for opioid dependence

  2009cites this paper
• The Development of ProNeura Technology for the Treatment of Addictions

  2009cites this paper
• Impact of One-Year Methadone Maintenance Treatment in Heroin Users in Jiangsu Province, China

  2009cites this paper
• Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence

  2009cites this paper
• Open-label dose-finding trial of buprenorphine implants (Probuphine) for treatment of heroin dependence.

  2009cites this paper
• Buprenorphine-naloxone versus methadone maintenance therapy: A randomised double-blind trial with opioid-dependent patients

  2008cites this paper
• Evaluation of therapeutic alternatives to imprisonment for drug-dependent offenders. Findings of a comparative European multi-country study

  2008cites this paper
• Multi-centre observational study of buprenorphine use in 32 Italian drug addiction centres.

  2008cites this paper
• Attitudes and knowledge of substance misusers regarding buprenorphine and methadone maintenance therapy

  2008cites this paper
• Clinical and psychosocial predictors of attendance and drug use in heroin users undergoing treatment

  2008cites this paper
• Role of implantable cardioverter-defibrillators in patients with methadone-induced long QT syndrome.

  2008cites this paper
• A pilot study for a randomized controlled and patient preference trial of buprenorphine versus methadone maintenance treatment in the management of opiate dependent patients

  2008cites this paper